Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Franco Pazzucconi"'
Autor:
Giuliana Mombelli, Antonia Alberti, Gianni Origgi, Chiara Pavanello, Marina Parolini, Laura Calabresi, Renata De Maria, Michele Carenini, Paolo Maino, Franco Pazzucconi, Federica Orsi, Maria Giovanna Trivella
Publikováno v:
Frontiers in Big Data
SKIM LEAN aims at exploiting Electronic Health Records (EHRs) to integrate knowledge derived from routine laboratory tests with background analysis of clinical databases, for the identification and early referral to specialist care, where appropriate
Autor:
Cesare Sirtori, Sara Simonelli, Franco Pazzucconi, Chiara Pavanello, Raffaella Bosisio, Giuliana Mombelli, Samuela Castelnuovo
Background: Cardiovascular risk (CV) factors associated with the metabolic syndrome (MetS) may vary in different populations. In some, hypertension may be the major determinant, in others are low high-density lipoprotein cholesterol (HDL-C), high tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::189cbac58b8585f5d18a7868674648ae
http://hdl.handle.net/2434/471350
http://hdl.handle.net/2434/471350
Autor:
Anna Maria Zanaboni, Cesare R. Sirtori, Giuliana Mombelli, Franco Pazzucconi, Sabrina Gaito, Alighiero Bondioli, Laura Calabresi
Publikováno v:
Cardiovascular Therapeutics. 28:153-160
Some recent clinical reports have suggested that paradoxical decreases in high-density lipoprotein cholesterol (HDL-C) levels after fenofibrate treatment may be quite common. These appear to occur mainly in patients with combined fibrate/statin thera
Autor:
F. Zoppi, Franco Pazzucconi, C. De Rosa, Alighiero Bondioli, G. Ferraro, Giuliana Mombelli, S Ferrara, Cesare R. Sirtori, Laura Calabresi, A. Agrati
Publikováno v:
Pharmacological Research. 50:105-108
The applicability of a kinetic model for the prediction of steady-state blood levels, based on body composition as assessed by bioelectric impedance analysis (BIA), was applied to a population of elderly patients, candidates for digoxin therapy. Elde
Autor:
Franco Pazzucconi, Laura Calabresi, Antonello Di Paolo, Cesare Sirtori, Mario Del Tacca, Stefano Ferrara
Publikováno v:
Pharmacological Research. 49:493-499
The association omeprazole/clarithromycin is of current wide use in the treatment of Helicobacter pylori associated gastroduodenal ulcer. This combination may result in increased levels of omeprazole with potential interactions with commonly associat
Autor:
Franco Pazzucconi, Cesare R. Sirtori, Laura Calabresi, Paolo Magni, Giuliana Mombelli, Chiara Pavanello, Raffaella Bosisio
Publikováno v:
Journal of clinical lipidology. 9(2)
Background Cardiovascular risk in men rises around the fourth decade of life, whereas women appear to be protected by sex hormones until menopause. This, in turn, tends to negatively affect the lipid profile. Since the 1980s, the incidence of cardiov
Autor:
Franco Pazzucconi, Elena Plasmati, Francesco Visioli, Patrizia Risé, Cesare R. Sirtori, Claudio Galli
Publikováno v:
Pharmacological Research. 41:571-576
Eight normolipidaemic volunteers, habitual partial skim milk drinkers and non-eaters of fish during the study, were given 500 ml day(-1) of partial skim milk for 1 month; they were then switched to 500 ml day(-1) of a novel commercially available mil
Autor:
Alighiero Bondioli, K. Descheemaeker, L. Colombo, Franco Pazzucconi, P. Battistin, Cesare R. Sirtori
Publikováno v:
British Journal of Nutrition. 82:91-96
Total substitution of soyabean protein for animal protein in the diet has been repeatedly shown to lower plasma cholesterol levels in hypercholesterolaemic individuals. A new, highly palatable, high-protein soya drink may allow replacement of a signi
Autor:
Pascal Pfister, Alberto Corsini, Franco Pazzucconi, Remo Fumagalli, Lorenzo Arnaboldi, Cesare R. Sirtori, Rodolfo Paoletti
Publikováno v:
Journal of Cardiovascular Pharmacology. 31:773-778
The beneficial effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) on coronary events have generally been attributed to their hypocholesterolemic properties. Mevalonate and other intermediates of cholesterol synt
Autor:
Enzo Manzato, Gaetano Crepaldi, Stragliotto Eduardo Lino, Mario Mancini, Angela A. Rivellese, Rodolfo Paoletti, Franco Pazzucconi, Cesare R. Sirtori, Franco Pamparana
Publikováno v:
Atherosclerosis. 137:419-427
n-3 Fatty acids in the form of ethyl esters (EE) allow lower daily doses and improved compliance. Administration of n-3 fatty acids to patients with glucose intolerance has led to controversial findings, some studies indicating worsening of the disor